Ellis Investment Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $309K | Hold |
1,411
| – | – | 0.06% | 190 |
|
|
2025
Q1 | $316K | Hold |
1,411
| – | – | 0.07% | 179 |
|
|
2024
Q4 | $462K | Hold |
1,411
| – | – | 0.09% | 149 |
|
|
2024
Q3 | $424K | Hold |
1,411
| – | – | 0.08% | 157 |
|
|
2024
Q2 | $465K | Hold |
1,411
| – | – | 0.1% | 149 |
|
|
2024
Q1 | $558K | Hold |
1,411
| – | – | 0.12% | 134 |
|
|
2023
Q4 | $497K | Hold |
1,411
| – | – | 0.12% | 134 |
|
|
2023
Q3 | $529K | Hold |
1,411
| – | – | 0.14% | 124 |
|
|
2023
Q2 | $540K | Hold |
1,411
| – | – | 0.13% | 130 |
|
|
2023
Q1 | $489K | Hold |
1,411
| – | – | 0.13% | 138 |
|
|
2022
Q4 | $332K | Hold |
1,411
| – | – | 0.09% | 160 |
|
|
2022
Q3 | $347K | Hold |
1,411
| – | – | 0.1% | 147 |
|
|
2022
Q2 | $426K | Hold |
1,411
| – | – | 0.11% | 142 |
|
|
2022
Q1 | $579K | Hold |
1,411
| – | – | 0.14% | 126 |
|
|
2021
Q4 | $661K | Hold |
1,411
| – | – | 0.15% | 114 |
|
|
2021
Q3 | $599K | Hold |
1,411
| – | – | 0.15% | 111 |
|
|
2021
Q2 | $506K | Hold |
1,411
| – | – | 0.13% | 124 |
|
|
2021
Q1 | $398K | Hold |
1,411
| – | – | 0.11% | 136 |
|
|
2020
Q4 | $400K | Hold |
1,411
| – | – | 0.12% | 127 |
|
|
2020
Q3 | $387K | Hold |
1,411
| – | – | 0.14% | 114 |
|
|
2020
Q2 | $317K | Hold |
1,411
| – | – | 0.12% | 126 |
|
|
2020
Q1 | $211K | Hold |
1,411
| – | – | 0.1% | 125 |
|
|
2019
Q4 | $214K | Hold |
1,411
| – | – | 0.07% | 147 |
|
|
2019
Q3 | $197K | Hold |
1,411
| – | – | 0.07% | 148 |
|
|
2019
Q2 | $175K | Buy |
+1,411
| New | +$175K | 0.07% | 161 |
|